Reducing the Agonist Activity of Antiandrogens by a Dominant-negative Androgen Receptor Coregulator ARA70 in Prostate Cancer Cells

This publication has 36 references indexed in Scilit:

• Negative Regulation of MAPKK by Phosphorylation of a Conserved Serine Residue Equivalent to Ser212 of MEK1
  Journal of Biological Chemistry, 2003
• A Dominant-negative Mutant of Androgen Receptor Coregulator ARA54 Inhibits Androgen Receptor-mediated Prostate Cancer Growth
  Journal of Biological Chemistry, 2002
• Domain Interactions between Coregulator ARA70 and the Androgen Receptor (AR)
  Molecular Endocrinology, 2002
• Hormone Status Selects for Spontaneous Somatic Androgen Receptor Variants That Demonstrate Specific Ligand and Cofactor Dependent Activities in Autochthonous Prostate Cancer
  Journal of Biological Chemistry, 2001
• Cancer Statistics, 2001
  CA: A Cancer Journal for Clinicians, 2001
• Antiandrogens fail to block androstenedione‐mediated mutated androgen receptor transactivation in human prostate cancer cells
  International Journal of Urology, 2000
• RFG (ARA70, ELE1) Interacts with the Human Androgen Receptor in a Ligand-Dependent Fashion, but Functions Only Weakly as a Coactivator in Cotransfection Assays
  Molecular Endocrinology, 1999
• Differential Induction of the Androgen Receptor Transcriptional Activity by Selective Androgen Receptor Coactivators.
  The Keio Journal of Medicine, 1999
• Mutation of the Androgen-Receptor Gene in Metastatic Androgen-Independent Prostate Cancer
  New England Journal of Medicine, 1995
• Mutant androgen receptor detected in an advanced-stage prostatic carcinoma is activated by adrenal androgens and progesterone
  Molecular Endocrinology, 1993